Literature DB >> 7937540

Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymeric additives.

M Vrkljan1, T M Foster, M E Powers, J Henkin, W R Porter, H Staack, J F Carpenter, M C Manning.   

Abstract

Turbidimetric or light scattering assays can be used to determine the extent of aggregation in protein formulations. Using low molecular weight urokinase (LMW-UK) as a model protein, the effect of polymeric additives on heat-induced aggregation was evaluated. Previous work has shown that under 60 degrees C heat treatment, LMW-UK initially denatures and the unfolded protein associates to form soluble aggregates. Eventually, these aggregates associate to form a precipitate. The effects of polymers on the initial aggregation phase was examined. Hydroxyethyl (heta) starch, polyethylene glycol 4000, and gelatin were found to be effective, concentration-dependent inhibitors of aggregation, whereas polyvinylpyrrolidone (PVP) and polyethylene glycol 300 were ineffective. Overall, the effect of polymeric additives on the stability of thermally-stressed LMW-UK can be accounted for by preferential exclusion of the solute from the surface of the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937540     DOI: 10.1023/a:1018935420680

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

2.  Insulin aggregation in solution.

Authors:  M Dathe; K Gast; D Zirwer; H Welfle; B Mehlis
Journal:  Int J Pept Protein Res       Date:  1990-10

3.  Effect of freezing on aggregation of human growth hormone.

Authors:  B M Eckhardt; J Q Oeswein; T A Bewley
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

Review 4.  Protein--solvent interactions in pharmaceutical formulations.

Authors:  T Arakawa; Y Kita; J F Carpenter
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

5.  The mechanism of cryoprotection of proteins by solutes.

Authors:  J F Carpenter; J H Crowe
Journal:  Cryobiology       Date:  1988-06       Impact factor: 2.487

6.  Examination of insulin formulations using quasi-elastic light scattering.

Authors:  H Martindale; J Marsh; F R Hallett; A M Albisser
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

7.  Thermal stability of proteins in the presence of poly(ethylene glycols).

Authors:  L L Lee; J C Lee
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

8.  Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols.

Authors:  R Bhat; S N Timasheff
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

9.  Physical stabilization of acidic fibroblast growth factor by polyanions.

Authors:  D B Volkin; P K Tsai; J M Dabora; J O Gress; C J Burke; R J Linhardt; C R Middaugh
Journal:  Arch Biochem Biophys       Date:  1993-01       Impact factor: 4.013

10.  Mechanism of poly(ethylene glycol) interaction with proteins.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1985-11-19       Impact factor: 3.162

  10 in total
  10 in total

1.  Stability of human serum albumin during bioprocessing: denaturation and aggregation during processing of albumin paste.

Authors:  J J Lin; J D Meyer; J F Carpenter; M C Manning
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 2.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state.

Authors:  B S Kendrick; B S Chang; T Arakawa; B Peterson; T W Randolph; M C Manning; J F Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.

Authors:  B S Chang; R M Beauvais; T Arakawa; L O Narhi; A Dong; D I Aparisio; J F Carpenter
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

Review 6.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

7.  Effects of sucrose on the internal dynamics of azurin.

Authors:  Patrizia Cioni; Emilia Bramanti; Giovanni B Strambini
Journal:  Biophys J       Date:  2005-03-25       Impact factor: 4.033

8.  Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.

Authors:  Stephany Y Tzeng; Rohiverth Guarecuco; Kevin J McHugh; Sviatlana Rose; Evan M Rosenberg; Yingying Zeng; Robert Langer; Ana Jaklenec
Journal:  J Control Release       Date:  2016-05-11       Impact factor: 9.776

9.  Soft Nanotubes Derivatized with Short PEG Chains for Thermally Controllable Extraction and Separation of Peptides.

Authors:  Naohiro Kameta; Wuxiao Ding; Jiuchao Dong
Journal:  ACS Omega       Date:  2017-09-26

10.  Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment.

Authors:  Sung-Jin Kim; Bongkyun Park; Hyun Wook Huh; Young-Guk Na; Minki Kim; Mingu Han; Hyunmin Lee; Thi Mai Anh Pham; Hong-Ki Lee; Jae-Young Lee; Chan-Sik Kim; Jong-Suep Baek; Cheong-Weon Cho
Journal:  Pharmaceutics       Date:  2020-02-17       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.